KylanHodson

[TimAlerts] ECR was recently Downgraded across the board by Moody's ratings agency. Now it expects a 750- 850 Million Q4 earnings impairment charge. Here's the thing: ECR's market cap is only 289.48 Million and it already has debt of 538.80M

Bushwacker

[TimAlerts] i think in buying TERP you just put yourself at the will and mercy of SUNE so Ive personally stayed away from TERP

RichJr72

[TimAlerts] Thanks. I'm long SUNE and GBSN. I was going to take my profits from GBSN, then I saw FDA approval coming out soon. So, I added to my position

Bushwacker

[TimAlerts] SUNE i still think the Tepper accusations are all BS and won't get anywhere. BlueMountain Capital holds almost 15% of TERP and they also hold a stake in SUNE, a lot of people are also speculating that Tepper also holds SUNE but none of that has been verified.

Bushwacker

[TimAlerts] but we'll see, SUNE as we know has serious debt issues and earnings coming up 2/17

Bushwacker

[TimAlerts] SUNE yeah Einhorn has been up in SUNE from the beginning and he's still holding a load of shares, he wouldn't take this seat unless he was more than fully committed for the future.

KylanHodson

[TimAlerts] AIMT volatile Friday due to traders speculating on the Phase 3 trial of its lead product candidate for the treatment of peanut allergy, for which there are no approved treatments

Received 1 Karma
Page
of 118